Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia

DOI PDF 2 Citations
  • Guido Finazzi
    Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
  • Alessandra Carobbio
    Research Foundation, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
  • Paola Guglielmelli
    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
  • Chiara Cavalloni
    Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
  • Silvia Salmoiraghi
    Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
  • Alessandro M. Vannucchi
    Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
  • Mario Cazzola
    Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
  • Francesco Passamonti
    Division of Hematology, Department of Medicine, Ospedale di Circolo e Fondazione Macchi, Varese, Italy
  • Alessandro Rambaldi
    Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
  • Tiziano Barbui
    Research Foundation, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

Journal

  • Blood

    Blood 124 (16), 2611-2612, 2014-10-16

    American Society of Hematology

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top